Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aclaris Therapeutics, Inc. | Chief Financial Officer | Common Stock | 202K | $212K | $1.05 | Mar 10, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACRS | Aclaris Therapeutics, Inc. | Mar 10, 2022 | 1 | -$199K | 4 | Mar 14, 2022 | Chief Financial Officer |
ACRS | Aclaris Therapeutics, Inc. | Mar 1, 2022 | 8 | $0 | 4 | Mar 3, 2022 | Chief Financial Officer |
ACRS | Aclaris Therapeutics, Inc. | Feb 9, 2022 | 1 | -$17.6K | 4 | Feb 11, 2022 | Chief Financial Officer |
ACRS | Aclaris Therapeutics, Inc. | Feb 1, 2022 | 2 | $0 | 4 | Feb 3, 2022 | Chief Financial Officer |
ACRS | Aclaris Therapeutics, Inc. | Jun 1, 2021 | 4 | -$325K | 4 | Jun 2, 2021 | Chief Financial Officer |